Skip to main content
. 2022 Mar 25;6(4):e707. doi: 10.1097/HS9.0000000000000707

Table 1.

Comparison of CBA, FISH, and CMA for the Detection of Genomic Changes in CLL

Cytogenetic test Advantage (strength) of the test Disadvantage (weakness) of the test
CBA Genome-wide scan
Single cell analysis
Detection of balanced chromosome rearrangements (ie, translocations, inversions)
Sensitivity is circa 10% to 15% in routine analysis: 2 (loss) or 3 (gain) aberrant metaphases found in 20 analyzed cells
Detection of clonal evolution
Discovery of novel abnormalities (and complex karyotype)
Requires culturing of cells with B-cell mitogen (eg, IL2 + CpG) to increase sensitivity
Resolution limit is 10–20 Mb
Exact definition of rearrangements may not be evident by banding-analysis alone
Cannot detect regions of homozygosity (CN-LOH)
Analysis is laborious and slow (1 case at a time)
FISH Resolution is circa 150–900 kb, depending on probe-size
Sensitivity for detection of low level clones is around 3%–5% (usually 100–200 interphase nuclei scored)
Does not require cultured cells
Batch cases
Detects only abnormalities where the probe was designed for
Multiple FISH probes are required to look at diverse abnormalities (routinely in CLL a 4–5 probe panel)
Clonal evolution may be overlooked
Cannot detect regions of homozygosity (CN-LOH) or genomic instability (chromothrypsis)
CMA Whole genome scan
Resolution is 50 kb or less (depending on platform design)
Discovery of novel abnormalities (and genomic complexity)
Detection of regions of homozygosity (CN-LOH) if SNP-based platform
Significantly automated (batch cases)
Does not require cultured cells
Discovery of novel unbalanced abnormalities with exact definition of the regions (and genes) involved (within the limit of resolution)
Detection of (submicroscopic) regions with genomic instability/chromothripsis
Cannot detect balanced chromosome rearrangements
Detection of multiple clones is feasible but not evident
Sensitivity is 10%–20% (platform-dependent)
B-cell enrichment may be required if tumor burden is low

CBA = chromosome banding analysis; CLL = chronic lymphocytic leukemia; CMA = chromosome microarray analysis; CN-LOH = copy neutral loss of heterozygosity; FISH = fluorescence in situ hybridization.

Adapted from Cooley et al, Schoumans et al, and Chun et al.18,40,42